T1	Entity 156 171	Myeloperoxidase
T2	Entity 47 50	MPO
R1	Equiv Arg1:T2 Arg2:T1	
T3	SNP 23 43	genetic polymorphism
R2	SNP_coupled_gene Arg1:T3 Arg2:T2	
T4	Spec 0 19	A prospective study
T5	Association 90 94	risk
E1	Association:T5 bc:T6 snp_int:T3
R3	Speculation_marker Arg1:E1 Arg2:T4	
T6	Cancer 76 89	breast cancer
T7	Other_effect 52 70	antioxidant status
E2	Other_effect:T7 Agent:T3
T8	SNP 295 301	G-463A
T9	Entity 309 317	promoter
R4	SNP_location Arg1:T8 Arg2:T9	
R5	SNP_coupled_gene Arg1:T8 Arg2:T1	
T10	Association 364 368	risk
E3	Association:T10 snp_int:T8 bc:T12
T11	Effect_Type 352 360	decrease
T12	Cancer 372 385	breast cancer
R6	Effect_type_marker Arg1:E3 Arg2:T11	
T13	Entity 296 300	-463
R7	SNP_location Arg1:T8 Arg2:T13	
T14	Entity 295 296;300 301	G A
R8	Nucleotide_substitution Arg1:T8 Arg2:T14	
A1	Effect_Type E3 Decrease
T15	Entity 965 979	Dietary intake
T16	Entity 984 1009	plasma antioxidant levels
T17	Spec 1010 1013	may
T18	Association 1025 1036	association
E4	Association:T18 bc:T21 snp_int:T20
R9	Speculation_marker Arg1:E4 Arg2:T17	
T19	Entity 1049 1052	MPO
T20	SNP 1053 1065	polymorphism
R10	SNP_coupled_gene Arg1:T20 Arg2:T19	
T21	Cancer 1070 1083	breast cancer
R11	Risk_Factor Arg1:T20 Arg2:T16	
R12	Risk_Factor Arg1:T20 Arg2:T15	
T22	Entity 1260 1305	higher amounts of total fruits and vegetables
T23	Effect_Type 1014 1020	modify
R14	Effect_type_marker Arg1:E4 Arg2:T23	
T24	Entity 1241 1246	women
R15	Population_assignment Arg1:T20 Arg2:T24	
T25	Effect_Type 1175 1182	inverse
T26	Association 1183 1195	associations
E5	Association:T26 snp_int:T28 bc:T21
R13	Effect_type_marker Arg1:E5 Arg2:T25	
A2	Effect_Type E5 Decrease
T27	Entity 1201 1204	MPO
T28	SNP 1205 1213	genotype
R17	SNP_coupled_gene Arg1:T28 Arg2:T27	
T29	Level 1219 1234	more pronounced
R18	Level_marker Arg1:E5 Arg2:T29	
A3	Level E5 High
R19	Risk_Factor Arg1:T28 Arg2:T22	
T30	SNP 1205 1213	genotype
R16	SNP_coupled_gene Arg1:T30 Arg2:T27	
R20	Population_assignment Arg1:T30 Arg2:T24	
T31	Entity 1275 1305;1378 1393	of total fruits and vegetables low-consumption
R21	Risk_Factor Arg1:T30 Arg2:T31	
T32	Neg 1358 1361	not
T33	Association 1342 1353	association
E6	Association:T33 snp_int:T30 bc:T21
A4	Effect_Type E6 Decrease
R22	Negation_marker Arg1:E6 Arg2:T32	
R23	Effect_type_marker Arg1:E6 Arg2:T25	
T34	Association 1435 1448	relative risk
E7	Association:T34 bc:T21 snp_int:T38
T35	Level 1505 1509	0.44
R24	Effect_type_marker Arg1:E7 Arg2:T35	
T36	Entity 1469 1472	MPO
T37	Entity 1473 1483	homozygous
T38	SNP 1484 1491	variant
R25	Genotype Arg1:T38 Arg2:T37	
R26	SNP_location Arg1:T38 Arg2:T36	
T39	Entity 1534 1539	women
R27	Population_assignment Arg1:T38 Arg2:T39	
T40	Entity 1552 1587	highest level of plasma carotenoids
R28	Risk_Factor Arg1:T38 Arg2:T40	
A5	Level E7 Low
T41	Spec 1682 1685	may
T42	Association 1756 1760	risk
E8	Association:T42 snp_int:T45 bc:T46
T43	Effect_Type 1686 1692	modify
R29	Effect_type_marker Arg1:E8 Arg2:T43	
R30	Speculation_marker Arg1:E8 Arg2:T41	
T44	Entity 1721 1724	MPO
T45	SNP 1725 1737	polymorphism
R31	SNP_coupled_gene Arg1:T45 Arg2:T44	
T46	Cancer 1742 1755	breast cancer
T47	Entity 1640 1661;1665 1681	endogenous modulators oxidative stress
T48	Entity 1626 1635;1651 1661;1665 1681	exogenous modulators oxidative stress
R32	Risk_Factor Arg1:T45 Arg2:T47	
R33	Risk_Factor Arg1:T45 Arg2:T48	
